Nemours

Researchers are evaluating how vaccine funding by the National Health Insurance affects vaccination coverage among patients targeted by current vaccination recommendations in outpatient consultations within four healthcare institutions in the Ile-de-France region in France. The study aims to determine if dedicated funding for vaccine procurement can improve vaccination rates for vulnerable patients at risk of infections such as pertussis and pneumococcal disease. It also seeks to understand the influence of socio-economic factors and changes in healthcare providers' practices on vaccination coverage and record-keeping. The study involves providing vaccines funded by the National Health Insurance to patients during outpatient consultations. It targets pneumococcal vaccination for eligible patients aged 18 and older and pertussis vaccination for pregnant women following French recommendations. Questionnaires are completed by both patients and healthcare providers to gather information on vaccination practices and status. The study focuses on patients seen in outpatient consultations at participating institutions and includes pregnant women in maternity wards during and after pregnancy. Participants will be monitored for vaccination status at 3 months and 18 months after vaccine availability to measure coverage rates for pneumococcal and pertussis vaccines. Researchers will use patient and provider questionnaires, digital vaccination records, and hospital software to track vaccinations and assess changes in healthcare practices. The study also examines socio-economic impacts and plans to share findings to potentially expand vaccine funding agreements across healthcare institutions. Participation involves outpatient visits, maternity follow-ups, and data collection over the study period.